TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nordic Bioscience A/S
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
356,556
|
443,872
|
363,482 |
| Earnings before taxes |
64,865
|
195,498
|
170,988 |
| Total assets |
439,125
|
384,839
|
356,620 |
| Current assets |
308,233
|
265,209
|
252,384 |
| Current liabilities |
281,237
|
219,484
|
136,795 |
| Equity capital |
92,902
|
101,448
|
157,900 |
| - share capital |
15,082
|
14,155
|
13,412 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
21.2%
|
26.4%
|
44.3% |
| Turnover per employee |
2,377
|
2,959
|
2,423 |
| Profit as a percentage of turnover |
18.2%
|
44.0%
|
47.0% |
| Return on assets (ROA) | |||
| Current ratio |
109.6%
|
120.8%
|
184.5% |
| Return on equity (ROE) |
69.8%
|
192.7%
|
108.3% |
| Change turnover |
-116,376
|
60,240
|
363,482 |
| Change turnover % |
-25%
|
16% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.